Page last updated: 2024-08-17

methoxamine and Angiogenesis, Pathologic

methoxamine has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexander, IE; Angus, PW; Chin, R; Cunningham, SC; Habib, MR; Herath, CB; Mak, KY; Sharland, AF; Torresi, J1

Other Studies

1 other study(ies) available for methoxamine and Angiogenesis, Pathologic

ArticleYear
ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2015, Volume: 23, Issue:9

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cytokines; Dependovirus; Disease Models, Animal; Enzyme Activation; Gene Expression; Genetic Therapy; Genetic Vectors; Hepatic Stellate Cells; Inflammation Mediators; Injections, Intraperitoneal; Lipid Peroxidation; Liver Cirrhosis; Liver Function Tests; Male; MAP Kinase Signaling System; Methoxamine; Mice; NADPH Oxidases; Neovascularization, Pathologic; Organ Specificity; Oxidative Stress; Peptidyl-Dipeptidase A; RNA, Messenger

2015